BLCM Annual Net Income
-$24.97 M
-$15.27 M-157.32%
31 December 2022
Summary:
As of February 5, 2025, BLCM annual net profit is -$24.97 million, with the most recent change of -$15.27 million (-157.32%) on December 31, 2022. During the last 3 years, it has risen by +$87.50 million (+77.80%).BLCM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Quarterly Net Income
-$763.00 K
+$6.59 M+89.62%
01 September 2023
Summary:
As of February 5, 2025, BLCM quarterly net profit is -$763.00 thousand, with the most recent change of +$6.59 million (+89.62%) on September 1, 2023. Over the past year, it has increased by +$6.45 million (+89.42%).BLCM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM TTM Net Income
-$22.38 M
+$6.45 M+22.37%
01 September 2023
Summary:
As of February 5, 2025, BLCM TTM net profit is -$22.38 million, with the most recent change of +$6.45 million (+22.37%) on September 1, 2023. Over the past year, it has dropped by -$6.13 million (-37.75%).BLCM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLCM Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -157.3% | +89.4% | -37.8% |
| 3 y3 years | +77.8% | +14.0% | +59.7% |
| 5 y5 years | +72.8% | +96.8% | +80.1% |
BLCM Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +298.7% | -104.1% | -441.8% |
Bellicum Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$763.00 K(-89.6%) | -$22.38 M(-22.4%) |
| June 2023 | - | -$7.35 M(-8.9%) | -$28.83 M(+13.2%) |
| Mar 2023 | - | -$8.07 M(+30.2%) | -$25.48 M(+2.0%) |
| Dec 2022 | -$24.97 M(+157.3%) | -$6.20 M(-14.1%) | -$24.97 M(+53.7%) |
| Sept 2022 | - | -$7.21 M(+80.3%) | -$16.25 M(+108.3%) |
| June 2022 | - | -$4.00 M(-47.1%) | -$7.80 M(+30.0%) |
| Mar 2022 | - | -$7.56 M(-398.8%) | -$6.00 M(-38.2%) |
| Dec 2021 | -$9.71 M(+25.7%) | $2.53 M(+105.3%) | -$9.71 M(-248.2%) |
| Sept 2021 | - | $1.23 M(-156.0%) | $6.55 M(+47.9%) |
| June 2021 | - | -$2.20 M(-80.5%) | $4.43 M(-112.1%) |
| Mar 2021 | - | -$11.27 M(-160.0%) | -$36.56 M(+373.5%) |
| Dec 2020 | -$7.72 M(-93.1%) | $18.78 M(-2217.6%) | -$7.72 M(-86.1%) |
| Sept 2020 | - | -$887.00 K(-97.9%) | -$55.49 M(-36.0%) |
| June 2020 | - | -$43.19 M(-345.8%) | -$86.63 M(+23.1%) |
| Mar 2020 | - | $17.58 M(-160.6%) | -$70.37 M(-37.4%) |
| Dec 2019 | -$112.48 M(+14.7%) | -$28.98 M(-9.5%) | -$112.48 M(+1.6%) |
| Sept 2019 | - | -$32.03 M(+18.9%) | -$110.72 M(+8.0%) |
| June 2019 | - | -$26.94 M(+9.8%) | -$102.48 M(+2.8%) |
| Mar 2019 | - | -$24.53 M(-9.9%) | -$99.72 M(+1.7%) |
| Dec 2018 | -$98.04 M | -$27.22 M(+14.4%) | -$98.04 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$23.80 M(-1.5%) | -$92.73 M(+0.4%) |
| June 2018 | - | -$24.18 M(+5.8%) | -$92.36 M(-0.3%) |
| Mar 2018 | - | -$22.84 M(+4.2%) | -$92.65 M(+0.9%) |
| Dec 2017 | -$91.78 M(+32.6%) | -$21.92 M(-6.5%) | -$91.78 M(+2.2%) |
| Sept 2017 | - | -$23.43 M(-4.2%) | -$89.80 M(+6.8%) |
| June 2017 | - | -$24.46 M(+11.3%) | -$84.09 M(+10.4%) |
| Mar 2017 | - | -$21.97 M(+10.2%) | -$76.14 M(+10.0%) |
| Dec 2016 | -$69.24 M(+42.6%) | -$19.94 M(+12.5%) | -$69.24 M(+4.7%) |
| Sept 2016 | - | -$17.72 M(+7.3%) | -$66.15 M(+7.0%) |
| June 2016 | - | -$16.51 M(+9.5%) | -$61.84 M(+10.7%) |
| Mar 2016 | - | -$15.07 M(-10.5%) | -$55.87 M(+15.1%) |
| Dec 2015 | -$48.55 M(-42.2%) | -$16.85 M(+25.7%) | -$48.55 M(-54.2%) |
| Sept 2015 | - | -$13.41 M(+27.3%) | -$106.00 M(+9.6%) |
| June 2015 | - | -$10.53 M(+35.8%) | -$96.69 M(+8.1%) |
| Mar 2015 | - | -$7.76 M(-89.6%) | -$89.43 M(+6.5%) |
| Dec 2014 | -$83.97 M(+953.6%) | -$74.30 M(+1713.9%) | -$83.97 M(+590.5%) |
| Sept 2014 | - | -$4.10 M(+24.8%) | -$12.16 M(+50.8%) |
| June 2014 | - | -$3.28 M(+43.3%) | -$8.06 M(+68.6%) |
| Mar 2014 | - | -$2.29 M(-8.2%) | -$4.78 M(+91.8%) |
| Dec 2013 | -$7.97 M(+27.2%) | -$2.49 M | -$2.49 M |
| Dec 2012 | -$6.26 M | - | - |
FAQ
- What is Bellicum Pharmaceuticals annual net profit?
- What is the all time high annual net income for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual net income year-on-year change?
- What is Bellicum Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals quarterly net income year-on-year change?
- What is Bellicum Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals TTM net income year-on-year change?
What is Bellicum Pharmaceuticals annual net profit?
The current annual net income of BLCM is -$24.97 M
What is the all time high annual net income for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual net profit is -$6.26 M
What is Bellicum Pharmaceuticals annual net income year-on-year change?
Over the past year, BLCM annual net profit has changed by -$15.27 M (-157.32%)
What is Bellicum Pharmaceuticals quarterly net profit?
The current quarterly net income of BLCM is -$763.00 K
What is the all time high quarterly net income for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly net profit is $18.78 M
What is Bellicum Pharmaceuticals quarterly net income year-on-year change?
Over the past year, BLCM quarterly net profit has changed by +$6.45 M (+89.42%)
What is Bellicum Pharmaceuticals TTM net profit?
The current TTM net income of BLCM is -$22.38 M
What is the all time high TTM net income for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high TTM net profit is $6.55 M
What is Bellicum Pharmaceuticals TTM net income year-on-year change?
Over the past year, BLCM TTM net profit has changed by -$6.13 M (-37.75%)